Ivy Pin-Fang Chen has a diverse background in biomedical science, genetics, and developmental biology. With experience ranging from undergraduate research to Ph.D. graduate assistant roles, Ivy is now a Regulatory Strategy Manager at Tessera Therapeutics. Ivy's work involves partnering with regulators for transparent communication to advance product development and preparing high-quality submissions based on science and data-driven arguments. Prior roles included validating gene editing technology and establishing biobanking processes using iPSCs at Boston Children's Hospital, as well as studying genomic imprinting in neurons during graduate school. Additionally, Ivy has a Bachelor of Arts degree in Biochemistry and Molecular Biology from Wesleyan University.
February, 2023 - present
July, 2022
January, 2021